We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy
HRD has emerged as a crucial biomarker to determine the eligibility of ovarian and breast cancer patients for PARP inhibitor and platinum-based therapies, offering the potential to enhance cancer treatment outcomes. CD FFPE HRD Reference materials are a groundbreaking solution aimed at advancing the assessment of genomic instability resulting from homologous recombination DNA repair deficiency (HRD).
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.
Method: | Validated Method: NGS |
Application: | CD FFPE HRD Reference materials are designed to support the development, validation, and routine determination of HRD status in cancer research. |
Storage: | Store at 2-8°C |
Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to info@cd-genomics.com for inquiries.
Please fill out the form below: ×